Dati da EMA (European Medicines Agency) - Curati da EPG Health - Ultimo aggiornamento 14 August 2018
Un'Area di apprendimento (AA) di epgonline.org è un'area del sito dedicata a fornire una formazione medica dettagliata e autogestita su una patologia, una malattia o una procedura.
The Cardiovascular Metabolism Knowledge Centre is an information hub providing expert insight into the management of hypertension and type 2 diabetes. This Knowledge Centre contains a wealth of scientific video content offering insights and opinion from some of the leading experts in the field.
Explore the pathophysiology, epidemiology and multi-system symptoms associated with hereditary ATTR amyloidosis, as well as how to achieve an early and accurate diagnosis.
Anticoagulation therapy for Stroke Prevention Learning Zone offers a deep-dive into atrial fibrillation causes, consequences, diagnosis and management to help you deliver optimal care and prevent strokes in patients living with this common arrhythmia.
ESICM LIVES Congress 2018: Bringing you the latest news and insights from the 31st ESICM LIVES Congress, 20–24 October 2018 Paris, France.
Sleep apnea is a chronic condition characterised by recurrent interruptions in breathing throughout the sleep cycle. Learn about the two main types of sleep apnea and hear from experts as they present the latest research at the Sleep and Breathing conference (Marseille, 2019).
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive fibrotic interstitial lung disease that occurs mostly in older adults, is limited to the lungs and often displays a characteristic imaging and histological appearance. Find out how to diagnose IPF and the latest interventions available for patients living with this burden.
Sei aggiornato sugli ultimi dati relativi all'efficacia delle procedure per il trattamento della ritenzione di liquidi?
+ 2 more
Biosimilars are uniquely placed to change clinical practice in the fields of gastroenterology, rheumatology, and dermatology. The adoption of biosimilars can improve patient access to the most appropriate treatment, at the optimum time, to ensure the best possible long-term disease outcomes.
Nessun argomento correlato Trial clinici trovato
Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course and management.
Background: Dual inhibition of the mitogen-activated protein kinase pathway with BRAF/MEK inhibitor (BRAFi/MEKi) therapy is a standard treatment for BRAFV600-mutant metastatic melanoma and has...
Aggiunto 5 mesi fa
Nessun argomento correlato Linee guida trovato
|Numero prodotto agenzia||EMEA/H/C/001068|
|Data di prima approvazione||16-10-2009|
|Tipo||Medicinale soggetto a prescrizione medica|
|Titolare dell'autorizzazione all'immissione in commercio||Novartis Europharm Limited|